Background: Cerebrospinal-fluid (CSF) Alzheimer’s Disease (AD) biomarkers have been extensively studied in Parkinson’s Disease (PD). Although reduced CSF beta-amyloid1-42 (Aβ42) levels have been associated with cognitive decline in PD, the alteration of CSF tau proteins remains controversial. In addition, the impairment of the blood-brain barrier (BBB) has been previously demonstrated along the PD progression. Objective: The aim of the present study was to assess CSF AD biomarkers and BBB integrity in a natural cohort of cognitive intact PD patients compared to matched controls. Method: We measured and correlated CSF AD biomarkers and CSF/serum albumin ratio (expression of BBB integrity) in 124 PD patients and 46 controls. We distributed PD...
The diagnostic guidelines of Alzheimer's disease (AD) have recently been updated to include brain im...
Progressive cognitive decline in combination with a cerebrospinal fluid biomarker pattern of low lev...
In early-stage Parkinson's disease (PD), cognitive impairment is common, and a variety of cognitive ...
Suffering from dementia, such as Alzheimer’s disease ("AD") and Parkinson’s disease with dementia ("...
In recent years, several studies have discovered traces of Alzheimer's (AD) biomarkers in a large po...
A connection between dementias and blood-brain barrier (BBB) dysfunction has been suggested, but pre...
ObjectiveWe analyzed the longitudinal profile of Alzheimer's disease (AD) cerebrospinal fluid (CSF) ...
Objective: To evaluate the evolution of cognitive impairment in relation to cerebrospinal fluid (CSF...
Alzheimer disease (AD) and Parkinson disease (PD) are the most common neurodegenerative disorders. F...
Parkinson's disease is a neurodegenerative movement disorder with cognitive symptoms with similariti...
There is a great interest in developing cerebrospinal fluid (CSF) biomarkers for diagnosis and progn...
BACKGROUND: Alterations in blood-brain barrier permeability have been proposed to represent a releva...
The development of biomarkers to predict the progression of Parkinson's disease (PD) from its earlie...
International audienceOBJECTIVE: To investigate the relationship between cerebrospinal fluid (CSF) β...
Background: There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD)...
The diagnostic guidelines of Alzheimer's disease (AD) have recently been updated to include brain im...
Progressive cognitive decline in combination with a cerebrospinal fluid biomarker pattern of low lev...
In early-stage Parkinson's disease (PD), cognitive impairment is common, and a variety of cognitive ...
Suffering from dementia, such as Alzheimer’s disease ("AD") and Parkinson’s disease with dementia ("...
In recent years, several studies have discovered traces of Alzheimer's (AD) biomarkers in a large po...
A connection between dementias and blood-brain barrier (BBB) dysfunction has been suggested, but pre...
ObjectiveWe analyzed the longitudinal profile of Alzheimer's disease (AD) cerebrospinal fluid (CSF) ...
Objective: To evaluate the evolution of cognitive impairment in relation to cerebrospinal fluid (CSF...
Alzheimer disease (AD) and Parkinson disease (PD) are the most common neurodegenerative disorders. F...
Parkinson's disease is a neurodegenerative movement disorder with cognitive symptoms with similariti...
There is a great interest in developing cerebrospinal fluid (CSF) biomarkers for diagnosis and progn...
BACKGROUND: Alterations in blood-brain barrier permeability have been proposed to represent a releva...
The development of biomarkers to predict the progression of Parkinson's disease (PD) from its earlie...
International audienceOBJECTIVE: To investigate the relationship between cerebrospinal fluid (CSF) β...
Background: There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD)...
The diagnostic guidelines of Alzheimer's disease (AD) have recently been updated to include brain im...
Progressive cognitive decline in combination with a cerebrospinal fluid biomarker pattern of low lev...
In early-stage Parkinson's disease (PD), cognitive impairment is common, and a variety of cognitive ...